Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO15394 | Angelica decursiva | Species | Apiaceae | Eukaryota | TCMID* | |||
NPO28932 | Myrrhis odorata | Species | Apiaceae | Eukaryota | TCMID* | |||
NPO24559.1 | Cotinus coggygria var. cinerea | Varieties | Anacardiaceae | Eukaryota | TCMID* | |||
NPO11298 | Peucedanum ruthenicum | Species | Apiaceae | Eukaryota | TCMID* | |||
NPO163 | Daucus carota | Species | Apiaceae | Eukaryota | TCMID* | |||
NPO163 | Daucus carota | Species | Apiaceae | Eukaryota | TCM_Taiwan* | |||
NPO19017 | Prangos pabularia | Species | Apiaceae | Eukaryota | TCM_Taiwan* | |||
NPO20598 | Lythrum salicaria | Species | Lythraceae | Eukaryota |
PMID[24459770] |
|||
NPO30569 | Peucedanum tauricum | Species | Apiaceae | Eukaryota |
PMID[24660466] |
|||
NPO31043 | Opopanax hispidus | Species | Apiaceae | Eukaryota | Aerial parts |
PMID[25179742] |
||
NPO6004 | Peucedanum morisonii | Species | Apiaceae | Eukaryota | TCMID* | |||
NPO6997 | Anthriscus cerefolium | Species | Apiaceae | Eukaryota | TCMID* | |||
NPO19017 | Prangos pabularia | Species | Apiaceae | Eukaryota | TCMID* | |||
NPO24780 | Oppopanax chironium | NA | NA | NA | TCMID* | |||
NPO4934 | Phaseolus vulgaris | Species | Fabaceae | Eukaryota | TCMID* | |||
NPO4849 | Peucedanum stenocarpum | Species | Apiaceae | Eukaryota | TCMID* | |||
NPO5201 | Peucedanum officinale | Species | Apiaceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 25118.9 | nM | PubChem BioAssay data set |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT536 | Uncleic Acid | microRNA 21 | Homo sapiens | Potency | = | 11668.1 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | Potency | = | 1995.3 | nM | PubChem BioAssay data set |
NPT538 | Individual Protein | Niemann-Pick C1 protein | Homo sapiens | Potency | = | 2818.4 | nM | PubChem BioAssay data set |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 29081 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 125892.5 | nM | PubChem BioAssay data set | ||
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 2332.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 6513.1 | nM | PubChem BioAssay data set | ||
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | 398.1 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 6309.6 | nM | PubChem BioAssay data set | ||
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 1412.5 | nM | PubChem BioAssay data set | |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT156 | Individual Protein | Sphingomyelin phosphodiesterase | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1122 | nM | PubChem BioAssay data set | ||
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 105.23 | % | 23571415 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 101.26 | % | 23571415 |
NPT2 | Others | Unspecified | Potency | 4610.9 | nM | PubChem BioAssay data set | ||
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 5173.5 | nM | PubChem BioAssay data set | |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 2310.9 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC98028 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.947 | High Similarity | NPC33320 |
0.9408 | High Similarity | NPC243509 |
0.9375 | High Similarity | NPC254010 |
0.9346 | High Similarity | NPC216092 |
0.9236 | High Similarity | NPC262635 |
0.9226 | High Similarity | NPC179464 |
0.9211 | High Similarity | NPC19860 |
0.9178 | High Similarity | NPC313036 |
0.9167 | High Similarity | NPC179015 |
0.9167 | High Similarity | NPC173149 |
0.9161 | High Similarity | NPC234536 |
0.9161 | High Similarity | NPC78612 |
0.9108 | High Similarity | NPC210460 |
0.9108 | High Similarity | NPC155264 |
0.9108 | High Similarity | NPC67450 |
0.9108 | High Similarity | NPC193881 |
0.9079 | High Similarity | NPC131725 |
0.9067 | High Similarity | NPC88445 |
0.906 | High Similarity | NPC74539 |
0.906 | High Similarity | NPC304443 |
0.9048 | High Similarity | NPC166858 |
0.9048 | High Similarity | NPC51146 |
0.9034 | High Similarity | NPC36414 |
0.9007 | High Similarity | NPC191104 |
0.9 | High Similarity | NPC266743 |
0.8987 | High Similarity | NPC323137 |
0.8938 | High Similarity | NPC51404 |
0.8926 | High Similarity | NPC246903 |
0.8897 | High Similarity | NPC472516 |
0.8896 | High Similarity | NPC278010 |
0.8896 | High Similarity | NPC250769 |
0.8896 | High Similarity | NPC295608 |
0.8861 | High Similarity | NPC15819 |
0.8854 | High Similarity | NPC264293 |
0.8844 | High Similarity | NPC472515 |
0.8836 | High Similarity | NPC253616 |
0.882 | High Similarity | NPC144288 |
0.8805 | High Similarity | NPC204088 |
0.8805 | High Similarity | NPC259007 |
0.8805 | High Similarity | NPC329215 |
0.88 | High Similarity | NPC208584 |
0.879 | High Similarity | NPC169 |
0.8784 | High Similarity | NPC470856 |
0.8767 | High Similarity | NPC268081 |
0.8767 | High Similarity | NPC29638 |
0.8742 | High Similarity | NPC190572 |
0.8734 | High Similarity | NPC14822 |
0.8733 | High Similarity | NPC17262 |
0.872 | High Similarity | NPC107244 |
0.8716 | High Similarity | NPC473209 |
0.8716 | High Similarity | NPC136095 |
0.8712 | High Similarity | NPC233956 |
0.871 | High Similarity | NPC41719 |
0.8707 | High Similarity | NPC103001 |
0.8704 | High Similarity | NPC281835 |
0.8701 | High Similarity | NPC474388 |
0.8701 | High Similarity | NPC472535 |
0.8701 | High Similarity | NPC474170 |
0.8684 | High Similarity | NPC129650 |
0.8684 | High Similarity | NPC117463 |
0.8671 | High Similarity | NPC239270 |
0.8671 | High Similarity | NPC303210 |
0.8671 | High Similarity | NPC49009 |
0.8671 | High Similarity | NPC95472 |
0.8662 | High Similarity | NPC269495 |
0.8659 | High Similarity | NPC53917 |
0.8659 | High Similarity | NPC224165 |
0.8636 | High Similarity | NPC155882 |
0.8636 | High Similarity | NPC177839 |
0.8627 | High Similarity | NPC211811 |
0.8609 | High Similarity | NPC76657 |
0.859 | High Similarity | NPC279930 |
0.8562 | High Similarity | NPC12148 |
0.8562 | High Similarity | NPC299923 |
0.8562 | High Similarity | NPC130581 |
0.8562 | High Similarity | NPC302741 |
0.8553 | High Similarity | NPC294365 |
0.8553 | High Similarity | NPC171656 |
0.8544 | High Similarity | NPC270044 |
0.8543 | High Similarity | NPC53192 |
0.8535 | High Similarity | NPC284353 |
0.8535 | High Similarity | NPC471746 |
0.8535 | High Similarity | NPC276059 |
0.8535 | High Similarity | NPC34725 |
0.8535 | High Similarity | NPC241774 |
0.8535 | High Similarity | NPC122623 |
0.8533 | High Similarity | NPC474037 |
0.8526 | High Similarity | NPC288534 |
0.8516 | High Similarity | NPC148423 |
0.8516 | High Similarity | NPC135303 |
0.8506 | High Similarity | NPC135325 |
0.8497 | Intermediate Similarity | NPC51641 |
0.8497 | Intermediate Similarity | NPC470322 |
0.8497 | Intermediate Similarity | NPC154217 |
0.8497 | Intermediate Similarity | NPC210826 |
0.8497 | Intermediate Similarity | NPC300267 |
0.8497 | Intermediate Similarity | NPC310259 |
0.8493 | Intermediate Similarity | NPC229646 |
0.8493 | Intermediate Similarity | NPC55147 |
0.8487 | Intermediate Similarity | NPC225884 |
0.8487 | Intermediate Similarity | NPC302181 |
0.8485 | Intermediate Similarity | NPC62640 |
0.8485 | Intermediate Similarity | NPC72455 |
0.8481 | Intermediate Similarity | NPC129053 |
0.8481 | Intermediate Similarity | NPC321372 |
0.8481 | Intermediate Similarity | NPC475797 |
0.8481 | Intermediate Similarity | NPC109967 |
0.8481 | Intermediate Similarity | NPC469936 |
0.8481 | Intermediate Similarity | NPC470625 |
0.8481 | Intermediate Similarity | NPC474609 |
0.8481 | Intermediate Similarity | NPC257277 |
0.8481 | Intermediate Similarity | NPC78554 |
0.8481 | Intermediate Similarity | NPC474738 |
0.8477 | Intermediate Similarity | NPC27220 |
0.8471 | Intermediate Similarity | NPC475895 |
0.8471 | Intermediate Similarity | NPC186507 |
0.8462 | Intermediate Similarity | NPC189773 |
0.8462 | Intermediate Similarity | NPC290671 |
0.8457 | Intermediate Similarity | NPC187923 |
0.8456 | Intermediate Similarity | NPC38153 |
0.8456 | Intermediate Similarity | NPC332594 |
0.8452 | Intermediate Similarity | NPC164299 |
0.8452 | Intermediate Similarity | NPC221868 |
0.8452 | Intermediate Similarity | NPC474648 |
0.8452 | Intermediate Similarity | NPC226644 |
0.8452 | Intermediate Similarity | NPC37208 |
0.8452 | Intermediate Similarity | NPC39929 |
0.8452 | Intermediate Similarity | NPC37226 |
0.8452 | Intermediate Similarity | NPC296030 |
0.8447 | Intermediate Similarity | NPC219861 |
0.8447 | Intermediate Similarity | NPC272722 |
0.8446 | Intermediate Similarity | NPC104796 |
0.8442 | Intermediate Similarity | NPC471285 |
0.8442 | Intermediate Similarity | NPC198427 |
0.8438 | Intermediate Similarity | NPC19554 |
0.8438 | Intermediate Similarity | NPC115432 |
0.8438 | Intermediate Similarity | NPC74749 |
0.8438 | Intermediate Similarity | NPC260296 |
0.8438 | Intermediate Similarity | NPC43971 |
0.8435 | Intermediate Similarity | NPC292998 |
0.8435 | Intermediate Similarity | NPC247743 |
0.8431 | Intermediate Similarity | NPC230943 |
0.8431 | Intermediate Similarity | NPC1886 |
0.8431 | Intermediate Similarity | NPC196137 |
0.8431 | Intermediate Similarity | NPC471590 |
0.8428 | Intermediate Similarity | NPC310206 |
0.8418 | Intermediate Similarity | NPC108937 |
0.8418 | Intermediate Similarity | NPC469934 |
0.8418 | Intermediate Similarity | NPC279218 |
0.8411 | Intermediate Similarity | NPC28337 |
0.8408 | Intermediate Similarity | NPC130015 |
0.8408 | Intermediate Similarity | NPC38361 |
0.8408 | Intermediate Similarity | NPC68882 |
0.8408 | Intermediate Similarity | NPC304954 |
0.8405 | Intermediate Similarity | NPC472895 |
0.8397 | Intermediate Similarity | NPC472406 |
0.8397 | Intermediate Similarity | NPC5840 |
0.8397 | Intermediate Similarity | NPC189270 |
0.8395 | Intermediate Similarity | NPC39305 |
0.8395 | Intermediate Similarity | NPC1706 |
0.8395 | Intermediate Similarity | NPC1755 |
0.8395 | Intermediate Similarity | NPC263092 |
0.8395 | Intermediate Similarity | NPC59295 |
0.8395 | Intermediate Similarity | NPC65846 |
0.8389 | Intermediate Similarity | NPC254741 |
0.8389 | Intermediate Similarity | NPC72452 |
0.8389 | Intermediate Similarity | NPC161196 |
0.8389 | Intermediate Similarity | NPC61546 |
0.8387 | Intermediate Similarity | NPC272194 |
0.8387 | Intermediate Similarity | NPC183236 |
0.8387 | Intermediate Similarity | NPC306788 |
0.8378 | Intermediate Similarity | NPC66705 |
0.8377 | Intermediate Similarity | NPC473927 |
0.8377 | Intermediate Similarity | NPC306488 |
0.8377 | Intermediate Similarity | NPC181388 |
0.8377 | Intermediate Similarity | NPC178343 |
0.8377 | Intermediate Similarity | NPC5820 |
0.8375 | Intermediate Similarity | NPC113055 |
0.8375 | Intermediate Similarity | NPC244750 |
0.8375 | Intermediate Similarity | NPC250076 |
0.8367 | Intermediate Similarity | NPC54503 |
0.8366 | Intermediate Similarity | NPC87609 |
0.8366 | Intermediate Similarity | NPC113089 |
0.8366 | Intermediate Similarity | NPC112791 |
0.8366 | Intermediate Similarity | NPC94794 |
0.8366 | Intermediate Similarity | NPC196459 |
0.8366 | Intermediate Similarity | NPC188632 |
0.8366 | Intermediate Similarity | NPC470216 |
0.8366 | Intermediate Similarity | NPC470296 |
0.8365 | Intermediate Similarity | NPC472461 |
0.8365 | Intermediate Similarity | NPC474983 |
0.8365 | Intermediate Similarity | NPC248299 |
0.8355 | Intermediate Similarity | NPC171870 |
0.8355 | Intermediate Similarity | NPC24075 |
0.8354 | Intermediate Similarity | NPC473664 |
0.8354 | Intermediate Similarity | NPC189130 |
0.8345 | Intermediate Similarity | NPC473894 |
0.8344 | Intermediate Similarity | NPC472407 |
0.8344 | Intermediate Similarity | NPC170169 |
0.8344 | Intermediate Similarity | NPC295650 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC98028 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.947 | High Similarity | NPD919 | Approved |
0.9236 | High Similarity | NPD1243 | Approved |
0.906 | High Similarity | NPD920 | Approved |
0.9048 | High Similarity | NPD643 | Clinical (unspecified phase) |
0.8926 | High Similarity | NPD642 | Clinical (unspecified phase) |
0.8854 | High Similarity | NPD1247 | Approved |
0.8609 | High Similarity | NPD6799 | Approved |
0.859 | High Similarity | NPD7096 | Clinical (unspecified phase) |
0.8526 | High Similarity | NPD6801 | Discontinued |
0.8428 | Intermediate Similarity | NPD7075 | Discontinued |
0.8418 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8397 | Intermediate Similarity | NPD6599 | Discontinued |
0.8312 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.8282 | Intermediate Similarity | NPD3926 | Phase 2 |
0.8267 | Intermediate Similarity | NPD2796 | Approved |
0.825 | Intermediate Similarity | NPD3882 | Suspended |
0.821 | Intermediate Similarity | NPD5494 | Approved |
0.8086 | Intermediate Similarity | NPD3749 | Approved |
0.8077 | Intermediate Similarity | NPD5401 | Approved |
0.8012 | Intermediate Similarity | NPD7819 | Suspended |
0.8 | Intermediate Similarity | NPD7411 | Suspended |
0.7975 | Intermediate Similarity | NPD5403 | Approved |
0.7961 | Intermediate Similarity | NPD3748 | Approved |
0.7961 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7933 | Intermediate Similarity | NPD1240 | Approved |
0.7922 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7922 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7911 | Intermediate Similarity | NPD1512 | Approved |
0.7862 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7857 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7857 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7848 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.784 | Intermediate Similarity | NPD1934 | Approved |
0.7829 | Intermediate Similarity | NPD1607 | Approved |
0.7826 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7791 | Intermediate Similarity | NPD2801 | Approved |
0.7791 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7785 | Intermediate Similarity | NPD1511 | Approved |
0.7765 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7751 | Intermediate Similarity | NPD7473 | Discontinued |
0.7744 | Intermediate Similarity | NPD5402 | Approved |
0.7742 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7733 | Intermediate Similarity | NPD6559 | Discontinued |
0.7727 | Intermediate Similarity | NPD2799 | Discontinued |
0.7707 | Intermediate Similarity | NPD3750 | Approved |
0.7706 | Intermediate Similarity | NPD3818 | Discontinued |
0.7697 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7692 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7679 | Intermediate Similarity | NPD6232 | Discontinued |
0.7677 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7667 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7661 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7651 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7647 | Intermediate Similarity | NPD1933 | Approved |
0.7643 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7643 | Intermediate Similarity | NPD2800 | Approved |
0.7636 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7628 | Intermediate Similarity | NPD2344 | Approved |
0.7588 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7588 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7588 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7586 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7566 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7566 | Intermediate Similarity | NPD2313 | Discontinued |
0.7566 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7532 | Intermediate Similarity | NPD447 | Suspended |
0.7516 | Intermediate Similarity | NPD2532 | Approved |
0.7516 | Intermediate Similarity | NPD2534 | Approved |
0.7516 | Intermediate Similarity | NPD2533 | Approved |
0.7516 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD7893 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD9717 | Approved |
0.7486 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7485 | Intermediate Similarity | NPD2403 | Approved |
0.7484 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7471 | Intermediate Similarity | NPD6797 | Phase 2 |
0.747 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7467 | Intermediate Similarity | NPD3267 | Approved |
0.7467 | Intermediate Similarity | NPD1203 | Approved |
0.7467 | Intermediate Similarity | NPD3266 | Approved |
0.7452 | Intermediate Similarity | NPD2935 | Discontinued |
0.7438 | Intermediate Similarity | NPD2309 | Approved |
0.7429 | Intermediate Similarity | NPD7251 | Discontinued |
0.7427 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7419 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7417 | Intermediate Similarity | NPD1019 | Discontinued |
0.7405 | Intermediate Similarity | NPD2355 | Clinical (unspecified phase) |
0.7405 | Intermediate Similarity | NPD2353 | Approved |
0.7384 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7381 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7375 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7371 | Intermediate Similarity | NPD5953 | Discontinued |
0.7356 | Intermediate Similarity | NPD7054 | Approved |
0.7355 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7333 | Intermediate Similarity | NPD3226 | Approved |
0.7329 | Intermediate Similarity | NPD3887 | Approved |
0.7315 | Intermediate Similarity | NPD422 | Phase 1 |
0.7315 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7314 | Intermediate Similarity | NPD7472 | Approved |
0.7314 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7312 | Intermediate Similarity | NPD2654 | Approved |
0.7308 | Intermediate Similarity | NPD6355 | Discontinued |
0.7297 | Intermediate Similarity | NPD17 | Approved |
0.7294 | Intermediate Similarity | NPD5537 | Clinical (unspecified phase) |
0.7288 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7283 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7267 | Intermediate Similarity | NPD6808 | Phase 2 |
0.7261 | Intermediate Similarity | NPD6651 | Approved |
0.7257 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7226 | Intermediate Similarity | NPD3268 | Approved |
0.7222 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7222 | Intermediate Similarity | NPD2354 | Approved |
0.7209 | Intermediate Similarity | NPD6959 | Discontinued |
0.7209 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7208 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.719 | Intermediate Similarity | NPD2798 | Approved |
0.7188 | Intermediate Similarity | NPD2346 | Discontinued |
0.7175 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.717 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7152 | Intermediate Similarity | NPD5049 | Phase 3 |
0.7152 | Intermediate Similarity | NPD1608 | Approved |
0.7143 | Intermediate Similarity | NPD4287 | Approved |
0.7134 | Intermediate Similarity | NPD943 | Approved |
0.7134 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7124 | Intermediate Similarity | NPD2797 | Approved |
0.7115 | Intermediate Similarity | NPD411 | Approved |
0.7115 | Intermediate Similarity | NPD6798 | Discontinued |
0.7101 | Intermediate Similarity | NPD6280 | Approved |
0.7101 | Intermediate Similarity | NPD6279 | Approved |
0.7089 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7089 | Intermediate Similarity | NPD230 | Phase 1 |
0.7089 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7069 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7063 | Intermediate Similarity | NPD7033 | Discontinued |
0.7055 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7055 | Intermediate Similarity | NPD1241 | Discontinued |
0.7041 | Intermediate Similarity | NPD5890 | Approved |
0.7041 | Intermediate Similarity | NPD5889 | Approved |
0.7029 | Intermediate Similarity | NPD5242 | Approved |
0.7024 | Intermediate Similarity | NPD7458 | Discontinued |
0.7022 | Intermediate Similarity | NPD1729 | Discontinued |
0.7018 | Intermediate Similarity | NPD4288 | Approved |
0.7018 | Intermediate Similarity | NPD5353 | Approved |
0.7006 | Intermediate Similarity | NPD2163 | Approved |
0.6982 | Remote Similarity | NPD6585 | Discontinued |
0.6974 | Remote Similarity | NPD1281 | Approved |
0.6973 | Remote Similarity | NPD7879 | Clinical (unspecified phase) |
0.6971 | Remote Similarity | NPD5710 | Approved |
0.6971 | Remote Similarity | NPD5711 | Approved |
0.6957 | Remote Similarity | NPD1509 | Clinical (unspecified phase) |
0.6948 | Remote Similarity | NPD3225 | Approved |
0.6948 | Remote Similarity | NPD1876 | Approved |
0.6933 | Remote Similarity | NPD9545 | Approved |
0.6928 | Remote Similarity | NPD3972 | Approved |
0.6919 | Remote Similarity | NPD2296 | Approved |
0.6918 | Remote Similarity | NPD4060 | Phase 1 |
0.6913 | Remote Similarity | NPD9493 | Approved |
0.691 | Remote Similarity | NPD3751 | Discontinued |
0.6903 | Remote Similarity | NPD1164 | Approved |
0.6901 | Remote Similarity | NPD37 | Approved |
0.689 | Remote Similarity | NPD1652 | Phase 2 |
0.6886 | Remote Similarity | NPD7004 | Clinical (unspecified phase) |
0.6886 | Remote Similarity | NPD3688 | Clinical (unspecified phase) |
0.6886 | Remote Similarity | NPD3146 | Approved |
0.6885 | Remote Similarity | NPD8055 | Clinical (unspecified phase) |
0.6879 | Remote Similarity | NPD5019 | Clinical (unspecified phase) |
0.6879 | Remote Similarity | NPD4967 | Phase 2 |
0.6879 | Remote Similarity | NPD4966 | Approved |
0.6879 | Remote Similarity | NPD4965 | Approved |
0.6865 | Remote Similarity | NPD8397 | Clinical (unspecified phase) |
0.6862 | Remote Similarity | NPD4362 | Clinical (unspecified phase) |
0.6862 | Remote Similarity | NPD4361 | Phase 2 |
0.6855 | Remote Similarity | NPD6233 | Phase 2 |
0.6852 | Remote Similarity | NPD651 | Clinical (unspecified phase) |
0.6848 | Remote Similarity | NPD7003 | Approved |
0.6842 | Remote Similarity | NPD6386 | Approved |
0.6842 | Remote Similarity | NPD6385 | Approved |
0.6842 | Remote Similarity | NPD7615 | Clinical (unspecified phase) |
0.6839 | Remote Similarity | NPD1283 | Approved |
0.6824 | Remote Similarity | NPD5808 | Clinical (unspecified phase) |
0.681 | Remote Similarity | NPD2438 | Suspended |
0.6806 | Remote Similarity | NPD4107 | Approved |
0.68 | Remote Similarity | NPD6234 | Discontinued |
0.6798 | Remote Similarity | NPD4575 | Clinical (unspecified phase) |
0.6792 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6792 | Remote Similarity | NPD3764 | Approved |
0.678 | Remote Similarity | NPD3787 | Discontinued |
0.6771 | Remote Similarity | NPD4482 | Phase 3 |
0.6768 | Remote Similarity | NPD6002 | Phase 3 |
0.6768 | Remote Similarity | NPD6003 | Clinical (unspecified phase) |
0.6768 | Remote Similarity | NPD6005 | Phase 3 |
0.6768 | Remote Similarity | NPD6006 | Clinical (unspecified phase) |
0.6768 | Remote Similarity | NPD6004 | Phase 3 |
0.6765 | Remote Similarity | NPD957 | Approved |
0.6765 | Remote Similarity | NPD1653 | Approved |
0.6758 | Remote Similarity | NPD6764 | Approved |
0.6758 | Remote Similarity | NPD6765 | Approved |
0.6753 | Remote Similarity | NPD1610 | Phase 2 |
0.675 | Remote Similarity | NPD4062 | Phase 3 |
0.6746 | Remote Similarity | NPD1940 | Clinical (unspecified phase) |
PubChem CID   | 8616 |
ChEMBL   | CHEMBL1410943 |
ZINC   |
Molecular Weight:   | 258.09 |
ALogP:   | 0.637 |
MLogP:   | 2.67 |
XLogP:   | 2.842 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 48.67 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 0 |
# Rings:   | 3 |
# Heavy Atoms:   | 19 |